Home > Cashflow Statement > GENPHARMASEC

GENPHARMASEC
Cashflow Statement

GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023
Profit Before Tax₹1.88 Cr₹0.25 Cr₹0.28 Cr
Adjustment ₹-1.04 Cr₹0.39 Cr₹0.16 Cr
Changes In working Capital ₹2.22 Cr₹-3.54 Cr₹-3.77 Cr
Cash Flow after changes in Working Capital ₹3.06 Cr₹-2.90 Cr₹-3.32 Cr
Cash Flow from Operating Activities ₹2.99 Cr₹-2.95 Cr₹-3.06 Cr
Cash Flow from Investing Activities ₹-15 Cr₹-28 Cr₹0.36 Cr
Cash Flow from Financing Activities ₹-1.25 Cr₹48 Cr₹3.08 Cr
Net Cash Inflow / Outflow ₹-14 Cr₹17 Cr₹0.39 Cr
Opening Cash & Cash Equivalents ₹19 Cr₹1.99 Cr₹1.61 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ---
Cash & Cash Equivalent of Subsidiaries under liquidations ---
Translation adjustment on reserves / op cash balalces frgn subsidiaries ---
Effect of Foreign Exchange Fluctuations ---
Closing Cash & Cash Equivalent ₹5.27 Cr₹19 Cr₹1.99 Cr

Compare Cashflow Statement of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹59.2 Cr 17.6% -9.3% -52.3% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹5,997.7 Cr -3.2% -13.1% -20.7% Stock Analytics
KIRI INDUSTRIES ₹2,252.4 Cr -0.1% -17% -42% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,573.3 Cr 12.2% 1.6% -30% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,003.9 Cr -0.7% -2.1% 13.9% Stock Analytics
BODAL CHEMICALS ₹694.1 Cr -3.5% 17.6% -11.8% Stock Analytics


GENPHARMASEC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

17.6%

-9.3%

-52.3%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses